RIKEN Preventive Medicine & Diagnosis Innovation Program (PMI)
- Program Director:
- Yoshihide Hayashizaki
- (M.D., Ph.D.)
The Preventive Medicine & Diagnosis Innovation Program deploys a broad range of research resources in physics, chemistry, engineering, biology and medical science to develop and establish more efficient disease detection technology that allows better disease prevention. Research groups taking part in the program are working on the discovery of new biomarkers, the development of detection technology for clinical practice, and the development of diagnosis kits. The program promotes collaborations within RIKEN and with universities, research institutes and hospitals both inside and outside Japan.
Drug discovery platform units (in each RIKEN center and institute)
-
-
Nucleic Acid Diagnostic System Development Unit (CLST)
- Kengo Usui(Ph.D.)
-
-
Medical Information Platform Unit for Preventive Medicine (ACCC)
- Katsuhiro Watanabe